Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition

被引：88
|
作者：
Madden, Michael M. [2 ]
Muppidi, Avinash [2 ]
Li, Zhenyu [1 ]
Li, Xiaolong [1 ]
Chen, Jiandong [1 ]
Lin, Qing [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[2] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 05期
基金：
美国国家卫生研究院;
关键词：
Inhibitors; Protein-protein interaction; Dipolar cycloaddition; Cellular uptake; Stapled peptides; MDM2; ONCOPROTEIN; ALPHA-HELICES; IN-VIVO; P53; RECOGNITION; ACTIVATION; AFFINITY; APOPTOSIS; PROTEINS; PATHWAY;
D O I：
10.1016/j.bmcl.2011.01.004
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report the first application of a photoinduced 1,3-dipolar cycloaddition reaction to 'staple' a peptide dual inhibitor of the p53-Mdm2/Mdmx interactions. A series of stapled peptide inhibitors were efficiently synthesized and showed excellent dual inhibitory activity in ELISA assay. Furthermore, the positively charged, stapled peptides showed enhanced cellular uptake along with modest in vivo activity. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1472 / 1475
页数：4
相关论文
共 50 条
  • [31] Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
    Li, Xiang
    Gohain, Neelakshi
    Chen, Si
    Li, Yinghua
    Zhao, Xiaoyuan
    Li, Bo
    Tolbert, William D.
    He, Wangxiao
    Pazgier, Marzena
    Hu, Honggang
    Lu, Wuyuan
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (09) : 2655 - 2669
  • [32] Synthesis and evaluation of novel orally active p53-MDM2 interaction inhibitors
    Miyazaki, Masaki
    Naito, Hiroyuki
    Sugimoto, Yuuichi
    Yoshida, Keisuke
    Kawato, Haruko
    Okayama, Tooru
    Shimizu, Hironari
    Miyazaki, Masaya
    Kitagawa, Mayumi
    Seki, Takahiko
    Fukutake, Setsuko
    Shiose, Yoshinobu
    Aonuma, Masashi
    Soga, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4319 - 4331
  • [33] Design, synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors
    Si, Dongjuan
    Luo, Huijuan
    Zhang, Xiaomeng
    Yang, Kundi
    Wen, Hongmei
    Li, Wei
    Liu, Jian
    BIOORGANIC CHEMISTRY, 2021, 115
  • [34] Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
    Pazgiera, Marzena
    Liu, Min
    Zou, Guozhang
    Yuan, Weirong
    Li, Changqing
    Li, Chong
    Li, Jing
    Monbo, Juahdi
    Zella, Davide
    Tarasov, Sergey G.
    Lu, Wuyuan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) : 4665 - 4670
  • [35] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
    Bazanov, Daniil R.
    Pervushin, Nikolay, V
    Savin, Egor, V
    Tsymliakov, Michael D.
    Maksutova, Anita, I
    Sosonyuk, Sergey E.
    Kopeina, Gelina S.
    Lozinskaya, Natalia A.
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (12) : 2216 - 2227
  • [36] Synthesis, molecular docking, drug likeness, in silico toxicity and DFT studies of small molecules as p53-MDM2 interaction and COX-2 dual inhibitors
    Basha, N. Jeelan
    Akshay, KT.
    Mohan, RM.
    Javeed, Mohammad
    Sharma, Omkar Mukesh
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1322
  • [37] The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction
    Furet, Pascal
    Chene, Patrick
    De Pover, Alain
    Valat, Therese Stachyra
    Lisztwan, Joanna Hergovich
    Kallen, Joerg
    Masuya, Keiichi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) : 3498 - 3502
  • [38] Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors
    Hu, Chunqi
    Li, Xin
    Wang, Weisi
    Zhang, Lei
    Tao, Lulu
    Dong, Xiaowu
    Sheng, Rong
    Yang, Bo
    Hu, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (18) : 5454 - 5461
  • [39] Systematic 'foldamerization' of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans- or cis-2-aminocyclopentanecarboxylic acid residues
    Fortuna, Paulina
    Twarda-Clapa, Aleksandra
    Skalniak, Lukasz
    Ozga, Katarzyna
    Holak, Tad A.
    Berlicki, Lukasz
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [40] Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53-MDM2 Protein-Protein Interaction
    Beloglazkina, Anastasia
    Barashkin, Alexander
    Polyakov, Vladislav
    Kotovsky, German
    Karpov, Nikita
    Mefedova, Sofia
    Zagribelny, Bogdan
    Ivanenkov, Yan
    Kalinina, Marina
    Skvortsov, Dmitry
    Tafeenko, Victor
    Zyk, Nikolay
    Majouga, Alexander
    Beloglazkina, Elena
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2020, 56 (06) : 747 - 755
12345